An Open-Label Dose-Escalation Study to Evaluate XmAb24306 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT04250155 · COMPLETED
Trial details
- NCT number
- NCT04250155
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-09
- Primary completion
- 2026-05-27
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.